Singapore News - BioNTech SE, the vaccine-maker that partnered Pfizer to produce the widely used Covid-19 shot, will be designating Singapore as its regional headquarters for South-east Asia. It also plans to set up a messenger RNA (mRNA) manufacturing facility here, which can be used to. Read more at www.tnp.sg
The Straits Times
Vaccine maker BioNTech to set up regional HQ, manufacturing site in S pore
BioNTech s Singapore office is expected to be operational in 2023 and will create at least 80 jobs.PHOTO: AFP
https://str.sg/JtKZ
They can read the article in full after signing up for a free account.
Share link:
Or share via:
Sign up or log in to read this article in full
Sign up
All done! This article is now fully available for you
Read now
Get unlimited access to all stories at $0.99/month for the first 3 months.
Get unlimited access to all stories at $0.99/month for the first 3 months.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
BioNTech to Establish Regional Headquarters for South East Asia and First mRNA Manufacturing .
BioNTech SEMay 10, 2021 GMT
BioNTech to establish first regional hub in Asia Pacific region in Singapore
Planned state-of-the-art manufacturing site will support global supply of mRNA-based vaccines and therapeutics and provide a rapid response capability for south east Asia against potential future pandemic threats
Expansion plan supported by the Singapore Economic Development Board (EDB)
MAINZ, GERMANY, May 10, 2021 BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced plans to expand its global footprint to Asia with the establishment of its Regional Headquarters for south east Asia in Singapore. In addition to selecting Singapore as its future regional headquarters, BioNTech plans to establish a fully integrated mRNA manufacturing facility in Singapore
(2)
BioNTech to establish first regional hub in Asia Pacific region in Singapore
Planned state-of-the-art manufacturing site will support global supply of mRNA-based vaccines and therapeutics and provide a rapid response capability for south east Asia against potential future pandemic threats
Expansion plan supported by the Singapore Economic Development Board (EDB)
MAINZ, GERMANY, May 10, 2021 -
BioNTech SE(Nasdaq: BNTX, BioNTech or the Company ) today announced plans to expand its global footprint to Asia with the establishment of its Regional Headquarters for south east Asia in Singapore. In addition to selecting Singapore as its future regional headquarters, BioNTech plans to establish a fully integrated mRNA manufacturing facility in Singapore with support from the Singapore Economic Development Board. The new facility will provide regional and global supply capacity of BioNTech s growing pipeline of mRNA-based product candidates, as well as a rapid response production
BioNTech SE
BioNTech to Establish Regional Headquarters for South East Asia and First mRNA Manufacturing Facility in Singapore
BioNTech to Establish Regional Headquarters for South East Asia and First mRNA Manufacturing Facility in Singapore
BioNTech to establish first regional hub in Asia Pacific region in Singapore
Planned state-of-the-art manufacturing site will support global supply of mRNA-based vaccines and therapeutics and provide a rapid response capability for south east Asia against potential future pandemic threats
Expansion plan supported by the Singapore Economic Development Board (EDB)
MAINZ, GERMANY, May 10, 2021
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced plans to expand its global footprint to Asia with the establishment of its Regional Headquarters for south east Asia in Singapore. In addition to selecting Singapore as its future regional headquarters, BioNTech plans to establish a fully integrated mRNA manu